Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 10/2018

01-10-2018 | Headache (R B Halker, Section Editor)

The Neuralgias

Authors: Danielle Wilhour, Stephanie J. Nahas

Published in: Current Neurology and Neuroscience Reports | Issue 10/2018

Login to get access

Abstract

Purpose of Review

Neuralgias are characterized by pain in the distribution of a cranial or cervical nerve. Typically, they are brief, paroxysmal, painful attacks, although continuous neuropathic pain may occur. The most commonly encountered conditions are trigeminal, postherpetic, and occipital neuralgia. Less common neuralgias include glossopharyngeal, superior laryngeal, auriculotemporal, and nervus intermedius neuralgia, among others. The approach to diagnosis and treatment of this group of disorders is reviewed.

Recent Findings

Recent guidelines of medication administration, the use of botulinum toxin, and more targeted procedures have improved treatment of neuralgias.

Summary

Patients who present with neuralgias should have imaging studies to investigate for structural abnormalities unless the etiology is apparent. Management of both common and rare neuralgias can be challenging and is best guided by the most recent available evidence.
Literature
1.
Gadient PM, Smith JH. The neuralgias: diagnosis and management. Curr Neurol Neurosci Rep. 2014;14:459.CrossRefPubMed
2.
Smith JH, Cutrer FM. Numbness matters: a clinical review of trigeminal neuropathy. Cephalalgia. 2011;31:1131–44.CrossRefPubMed
3.
Cheshire WP Jr. Cranial neuralgias. Continuum (Minneap Minn). 2015;21(4):1072–85.PubMed
4.
Katusic S, Williams DB, Beard CM, et al. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945–1984. Neuroepidemiology. 1991;10(5–6):276–81.CrossRefPubMed
5.
van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–62.CrossRefPubMed
6.
De Santi L, Annunziata P. Symptomatic cranial neuralgias in multiple sclerosis: clinical features and treatment. Clin Neurol Neurosurg. 2012;114(2):101–7.CrossRefPubMed
7.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.CrossRef
8.
Rozen TD, Capobianco DJ, Dalessio DJ. Cranial neuralgias and other causes of facial pain. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff's headache and other head pain. New York: Oxford University Press; 2008. p. 633–50.
9.
Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183–90.CrossRefPubMed
10.
Crucco G. Trigeminal neuralgia. Continuum (Minneap Minn). 2017;23(2):396–420.
11.
Cheshire WP. Trigeminal neuralgia: for one nerve a multitude of treatments. Expert Rev Neurother. 2007;7(11):1565–79.CrossRefPubMed
12.
Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J Pain Symptom Manag. 2001;21(6):506–10.CrossRef
13.
Cheshire WP Jr. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain. 2002;3(2):137–42.CrossRefPubMed
14.
Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, et al. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review. J Headache Pain. 2013;14:72.
15.
Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32(6):443–50.CrossRefPubMed
16.
Zhang J, Yang M, Zhou M, et al. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev. 2013;12:CD004029.
17.
• Bick SK, Eskandar EN. Surgical treatment of trigeminal neuralgia. Neurosurg Clin N Am. 2017;28(3):429–38. This article reviews the different procedures and surgical options for patients with trigeminal neuralgia CrossRefPubMed
18.
Zakrzewska JM, Akram H. Neurosurgical interventions for the treatment of trigeminal neuralgia. Cochrane Database Syst Rev. 2011;9:CD007312.
19.
Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990;27(1):89–95.CrossRefPubMed
20.
21.
Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526–33.CrossRefPubMed
22.
•• Feller L, Khammissa RAG, Fourie J, Bouckaert M, Lemmer J. Postherpetic neuralgia and trigeminal neuralgia. Pain Res Treat. 2017;2017:1681765. This paper highlights the pathogenesis, clinical features, and treatment of postherpetic neuralgia and trigeminal neuralgia. PubMedPubMedCentral
23.
Drolet M, Brisson M, Schmader K, Levin M, Johnson R, Oxman M, et al. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J Pain. 2010;11:1211–21.CrossRefPubMed
24.
McDonald EM, de Kock J, Ram FS. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. Antivir Ther. 2012;17(2):255–64.CrossRefPubMed
25.
Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996;22:341–7.CrossRefPubMed
26.
Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;2:CD006866.
27.
Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994;330:896–900.CrossRefPubMed
28.
Whitley RJ, Weiss H, Gnann JW Jr, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med. 1996;125:376–83.CrossRefPubMed
29.
Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manag. 1997;13:327–31.CrossRef
30.
Zaal MJ, Volker-Dieben HJ, D’Amarao J. Prognostic value of Hutchinson’s sign in acute herpes zoster ophthalmicus. Graefes Arch Clin Exp Ophthalmol. 2003;241:187–91.CrossRefPubMed
31.
Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005;2:e164–4.CrossRefPubMedPubMedCentral
32.
Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237–51.CrossRefPubMed
33.
McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013;8:CD006146–6.
34.
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–84.
35.
Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67(3):103–8.CrossRefPubMedPubMedCentral
36.
• Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–96. This study shows that the the herpes Zoster subunit vaccine significantly reduced the risk of herpes zoster in adults who were at or above the age of 50 years old. CrossRefPubMed
37.
Hammond SR, Danta G. Occipital neuralgia. Clin Exp Neurol. 1978;15:258–70.PubMed
38.
39.
40.
Vanelderen P, Lataster A, Levy R, Mekhail N, van Kleef M, van Zundert J. Occipital neuralgia. Pain Pract. 2010;10:137–44.CrossRefPubMed
41.
Kapural L, Stillman M, Kapural M, McIntyre P, Guirgius M, Mekhail N. Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series. Pain Pract. 2007;7:337–40.CrossRefPubMed
42.
Taylor M, Silva S, Cottrell C. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study. Headache. 2008;48:1476–81.CrossRefPubMed
43.
Narouze S. Occipital neuralgia diagnosis and treatment: the role of ultrasound. Headache. 2016;56(4):801–7.CrossRefPubMed
44.
•• O'Neill F, Nurmikko T, Sommer C. Other facial neuralgias. Cephalalgia. 2017;37(7):658–69. The authors discuss the presentation, pathophysiology, and treatment of the rarer neuralgias. CrossRefPubMed
45.
46.
47.
Koopman JS, Dieleman JP, Huygen FJ, et al. Incidence of facial pain in the general population. Pain. 2009;147(1–3):122–7.CrossRefPubMed
48.
Patel A, Kassam A, Horowitz M, Chang YF. Microvascular decompression in the management of glossopharyngeal neuralgia: analysis of 217 cases. Neurosurgery. 2002;50:705–10.CrossRefPubMed
49.
Rey-Dios R, Cohen-Gadol AA. Current neurosurgical management of glossopharyngeal neuralgia and technical nuances for microvascular decompression surgery. Neurosurg Focus. 2013;34:E8.CrossRefPubMed
50.
51.
Stuck BA, Maurer JT, Mockel C, et al. Excessive weight loss caused by dysphagia in superior laryngeal nerve neuralgia: a case report. Laryngorhinootologie. 2000;79:548–50.CrossRefPubMed
52.
O’Neill BP, Aronson AE, Pearson BW, et al. Superior laryngeal neuralgia. Headache. 1982;22:6–9.CrossRefPubMed
53.
Baugh RF, Baugh A, Bunge F. Superior laryngeal nerve syndrome and the evaluation of anterior neck pain. Am J Otolaryngol. 2012;33:481–3.CrossRefPubMed
54.
Aydin O, Ozturk M, Anik Y. Superior laryngeal neuralgia after acute laryngitis and treatment with a single injection of a local anesthetic. Arch Otolaryngol Head Neck Surg. 2007;133:934–5.CrossRefPubMed
55.
Brownstone PK, Ballenger JJ, Vick NA. Bilateral superior laryngeal neuralgia: its successful treatment with carbamazepine. Arch Neurol. 1980;37:525.CrossRefPubMed
56.
Takahashi SK, Suzuki M, Izuha A, Hayashi S, Isosu T, Murakawa M. Two cases of idiopathic superior laryngeal neuralgia treated by superior laryngeal nerve block with a high concentration of lidocaine. J Clin Anesth. 2007;19:237–8.CrossRef
57.
Tang IP, Freeman SR, Kontorinis G, Tang MY, Rutherford SA, King AT, et al. Geniculate neuralgia: a systematic review. J Laryngol Otol. 2014;128:394–9.CrossRef
58.
Tubbs RS, Mosier KM, Cohen-Gadol AA. Geniculate neuralgia: clinical, radiologic, and intraoperative correlates. World Neurosurg. 2013;80(6):e353–7.CrossRefPubMed
59.
Ruiz M, Porta-Etessam J, Garcia-Ptacek S, de la Cruz C, Cuadrado ML, Guerrero AL. Auriculotemporal neuralgia: eight new cases report. Pain Med. 2016;17:1744–8.CrossRefPubMed
60.
61.
Damarjian E. Auriculotemporal neuralgia–an original diagnostic and therapeutic approach. R I Med J. 1970;53:100–1.PubMed
62.
Huang C, Amasanti M, Lovell B, Young T. Recurrent painful ophthalmoplegic neuropathy. Pract Neurol. 2017;17(4):318–20.CrossRefPubMed
63.
Förderreuther S, Ruscheweyh R. From ophthalmoplegic migraine to cranial neuropathy. Curr Pain Headache Rep. 2015;19:21.CrossRefPubMed
64.
Lal V, Sahota P, Singh P, Gupta A, Prabhakar S. Ophthalmoplegia with migraine in adults: is it ophthalmoplegic migraine? Headache. 2009;49:838–50.CrossRefPubMed
65.
Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol. 2012;27:759–66.CrossRefPubMedPubMedCentral
66.
67.
Gladstone JP. An approach to the patient with painful ophthalmoplegia, with a focus on Tolosa-Hunt syndrome. Curr Pain Headache Rep. 2007;11(4):317–25.CrossRefPubMed
68.
Hung CH, Chang KH, Wu YM, Chen YL, Lyu RK, Chang HS, et al. A comparison of benign and inflammatory manifestations of Tolosa-Hunt syndrome. Cephalalgia. 2013;33:842–52.CrossRefPubMed
69.
Zurawski J, Akhondi H. Tolosa-Hunt syndrome--a rare cause of headache and ophthalmoplegia. Lancet. 2013;382:912.CrossRefPubMed
70.
Solomon S, Lustig JP. Benign Raeder’s syndrome is probably a manifestation of carotid artery disease. Cephalalgia. 2001;21(1):1–11.CrossRefPubMed
71.
72.
73.
• Gelfand AA, Johnson H, Lenaerts ME, et al. Neck-tongue syndrome: a systematic review. Cephalalgia. 2018;38(2):374–82. This paper offers a literature review and case series of neck-tongue syndrome. CrossRefPubMed
74.
Sun A, Wu KM, Wang YP, Lin HP, Chen HM, Chiang CP. Burning mouth syndrome: a review and update. J Oral Pathol Med. 2013;42(9):649–55.CrossRefPubMed
75.
Maltsman-Tseikhin A, Moricca P, Niv D. Burning mouth syndrome: will better understanding yield better management? Pain Pract. 2007;7(2):151–62.CrossRefPubMed
Metadata
Title
The Neuralgias
Authors
Danielle Wilhour
Stephanie J. Nahas
Publication date
01-10-2018
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 10/2018
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-018-0880-0

Other articles of this Issue 10/2018

Current Neurology and Neuroscience Reports 10/2018 Go to the issue

Neuro-Oncology (LE Abrey, Section Editor)

Management of Brain Metastases in the New Era of Checkpoint Inhibition

Dementia (K S Marder, Section Editor)

The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions

Sleep (M Thorpy and M Billiard, Section Editors)

Sleep in Parkinson’s Disease with Impulse Control Disorder

Critical Care (SA Mayer, Section Editor)

Does Dexmedetomidine Ameliorate Postoperative Cognitive Dysfunction? A Brief Review of the Recent Literature

Sleep (M Thorpy and M Billiard, Section Editors)

Circadian Rhythm Disturbances in the Blind

Stroke (H Diener, Section Editor)

Detection of Atrial Fibrillation in Cryptogenic Stroke